WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global
UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) — Today, ATNi launches the 5th edition of the Global Access to Nutrition
UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) — Today, ATNi launches the 5th edition of the Global Access to Nutrition
UTRECHT, Pays-Bas, 07 nov. 2024 (GLOBE NEWSWIRE) — Aujourd’hui, l’ATNi lance la 5e édition de l’Indice mondial d’accès à la nutrition,
Leading Swiss law firm adopts scalable, intuitive solution to strengthen IP management capabilities BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) — Anaqua,
Leading Swiss law firm adopts scalable, intuitive solution to strengthen IP management capabilities BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) — Anaqua,
REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext
Libyan Newswire brings you the latest news and updates, covering advancements, innovations, and breakthroughs in various tech sectors.